Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 71 | 1,193 | 2,428 | 2,045 | 589 |
| Gross Profit | 71 | 1,193 | 2,428 | 2,045 | 589 |
| Operating Expenses | 75,024 | 55,025 | 31,138 | 11,172 | 6,633 |
| Operating Income | -74,953 | -53,832 | -28,710 | -9,127 | -6,044 |
| Interest Expense | 0 | 0 | 0 | 0 | 11 |
| Other Income | 1,141 | 3,410 | 1,595 | -30 | 36 |
| Pre-tax Income | -73,812 | -50,422 | -27,115 | -9,157 | -6,019 |
| Net Income Continuous | -73,812 | -50,422 | -27,115 | -9,157 | -6,019 |
| Net Income | $-73,812 | $-50,422 | $-27,115 | $-9,157 | $-6,019 |
| EPS Basic Total Ops | -2.42 | -2.09 | -2.23 | -6.68 | -5.96 |
| EPS Basic Continuous Ops | -2.42 | -2.09 | -2.23 | -6.68 | -5.95 |
| EPS Diluted Total Ops | -2.42 | -2.09 | -2.23 | -6.68 | -5.96 |
| EPS Diluted Continuous Ops | -2.42 | -2.09 | -2.23 | -6.68 | -5.95 |
| EPS Diluted Before Non-Recurring Items | -2.42 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-74,232 | $-54,174 | $-28,672 | $-8,999 | $-5,952 |